About

Publications While At HealthPartners

selected publications

Journal Article

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. 

Neurooncol Adv. 2023

Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies. 

British Journal of Cancer. 2023

The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma. 

Melanoma Research. 2023

Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy. 

Breast Cancer Research and Treatment. 2020

Phase I study of IGF-methotrexate conjugate in the treatment of advanced tumors expressing IGF-1R. 

American Journal of Clinical Oncology. 2019

Phase I study of aurora A kinase inhibitor alisertib (MLN8237) in combination with selective VEGFR inhibitor pazopanib for therapy of advanced solid tumors. 

American Journal of Clinical Oncology. 2019

Phase I study of pazopanib and ixabepilone in patients with solid tumors. 

American Journal of Clinical Oncology. 2016

Contact

full name

J. H. Fischer

Quick Info

 

Collaboration

Co-author network

Map of science